Frontiers in Medicine | |
Molecular Hydrogen: A Promising Adjunctive Strategy for the Treatment of the COVID-19 | |
Keliang Xie1  Naqi Lian2  Yuzun Wang2  Zhen Wang2  Yingning Li2  Weiqiang Zheng2  | |
[1] College of Anesthesiology, Translational Research Institute of Intensive Care Medicine, College of Anesthesiology, Weifang Medical University, Weifang, China;Department of Anesthesiology, Tianjin Medical University General Hospital, Tianjin Research Institute of Anesthesiology, Tianjin, China;Department of Critical Care Medicine, Tianjin Medical University General Hospital, Tianjin, China; | |
关键词: COVID-19; molecular hydrogen; inflammation; cytokines; treatment; | |
DOI : 10.3389/fmed.2021.671215 | |
来源: DOAJ |
【 摘 要 】
Coronavirus disease 2019 (COVID-19) is an acute respiratory disease caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has no specific and effective treatment. The pathophysiological process of the COVID-19 is an excessive inflammatory response after an organism infects with a virus. Inflammatory storms play an important role in the development of the COVID-19. A large number of studies have confirmed that hydrogen has a therapeutic effect on many diseases via inhibiting excessive inflammatory cells and factors. Recently, a study led by the Academician Zhong Nanshan in China on the treatment of the patients with the COVID-19 by inhalation of a mixed gas composed of hydrogen and oxygen has attracted widespread international attention and hydrogen therapy has also been included in a new treatment plan for the COVID-19 in China. This study mainly describes the mechanism of occurrence of the COVID-19, summarizes the therapeutic effects and underlying mechanisms of hydrogen on the critical disease, and analyzes the feasibility and potential therapeutic targets of hydrogen for the treatment of the COVID-19.
【 授权许可】
Unknown